Clinical Trial Update: Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy [Phase 3]

View source ↗

Summary

Phase 3 evaluation of Suzetrigine for pain associated with diabetic peripheral neuropathy is ongoing, focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathic Pain
• Diabetic Peripheral Neuropathy

Drugs mentioned

• Suzetrigine (Suzetrigine)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 3 | Status: RECRUITING